Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis.

Authors : Brandão M, Maurer C, Ziegelmann PK, Pondé NF, Ferreira A, Martel S, Piccart-Gebhart M, de Azambuja E, Debiasi M, Lambertini M
Year : 2020
Journal : ESMO Open
Volume : 5

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.

Authors : Franzoi MA, Vandeputte C, Eiger D, Caparica R, Brandão M, de Angelis C, Hendlisz A, Awada A, Piccart-Gebhart M, de Azambuja E
Year : 2020
Journal : Breast Cancer Res Treat
Volume : 181
Pages : 199-209

Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast Cancer.

Authors : Caparica R, Richard F, Brandão M, Awada A, Sotiriou C, de Azambuja E
Year : 2020
Journal : Clin Breast Cancer
Volume : 20
Pages : 262-273.e7

Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer.

Authors : Eiger D, Brandão M, de Azambuja E
Year : 2020
Journal : ESMO Open
Volume : 5

Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials.

Authors : Eiger D, Franzoi MA, Pondé N, Brandão M, de Angelis C, Schmitt Nogueira M, de Hemptinne Q, de Azambuja E
Year : 2020
Journal : ESMO Open
Volume : 5

What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?

Authors : Brandão M, Caparica R, Malorni L, Prat A, Carey LA, Piccart-Gebhart M
Year : 2020
Journal : Clin Cancer Res
Volume : 26
Pages : 2783-2788

Treatment and Other Healthcare Use of Breast Cancer Patients With a Previous Cancer Diagnosis.

Authors : Morais S, Costa AR, Lopes-Conceicao L, Brandão M, Borges M, Araujo N, Dias T, Fontes F, Pereira S, Lunet N
Year : 2020
Journal : Anticancer Res
Volume : 40
Pages : 1041-1048

Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an 'option' but an ethical obligation.

Authors : Brandão M, Reyal F, Hamy AS, Piccart-Gebhart M
Year : 2019
Journal : ESMO Open
Volume : 4
Pages : e000515

Denosumab in early-stage breast cancer.

Authors : Brandão M, Debiasi M, de Azambuja E
Year : 2019
Journal : Lancet Oncol
Volume : 20
Pages : e234-e235

Patient-reported outcomes and genomic signatures: tools to tailor adjuvant endocrine treatment?

Authors : Brandão M, Coens C, Ignatiadis M
Year : 2019
Journal : Ann Oncol
Volume : 30
Pages : 1677-1681

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors.

Authors : Brandão M, Caparica R, Eiger D, de Azambuja E
Year : 2019
Journal : Ann Oncol
Volume : 30 Suppl 10
Pages : x27-x42

Systemic treatment of patients with early breast cancer: recent updates and state of the art.

Authors : Caparica R, Brandão M, Piccart-Gebhart M
Year : 2019
Journal : Breast
Volume : 48 Suppl 1
Pages : S7-S20

Mammaprint™: a comprehensive review.

Authors : Brandão M, Pondé N, Piccart-Gebhart M
Year : 2019
Journal : Future Oncol
Volume : 15
Pages : 207-224

Evaluation of The Medical Board Exam in Portugal.

Authors : Marques TR, Laíns I, Martins MJ, Goiana-da-Silva F, Sampaio F, Pessanha I, Fernandes DH, Brandão M, Pinto Teixeira P, Oliveira Santos M, Silva JC, Ribeiro JC
Year : 2018
Journal : Acta Med Port
Volume : 31
Pages : 670-679

Marjolin's Ulcer with Axillary Lymph Node Metastasis.

Authors : Fernandes MG, Brandão M, Dias EM
Year : 2018
Journal : Acta Med Port
Volume : 31
Pages : 515

CDK4/6 inhibitors as neoadjuvant treatment in breast cancer - what can we learn?

Authors : Brandão M, Ignatiadis M
Year : 2018
Journal : Ann Oncol
Volume : 29(12)
Pages : 2274-2278

Treatment of advanced HER2-positive breast cancer: 2018 and beyond.

Authors : Pondé N, Brandão M, El-Hachem G, Werbrouck E, Piccart-Gebhart M
Year : 2018
Journal : Cancer Treat Rev
Volume : 67
Pages : 10-20

Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects.

Authors : Brandão M, Pondé NF, Poggio F, Kotecki N, Salis M, Lambertini M, de Azambuja E
Year : 2018
Journal : Expert Rev Anticancer Ther
Volume : 18
Pages : 629-649